Investigating Lysosomal Storage Diseases in Minority Groups
- Conditions
- Fabry DiseaseLysosomal Storage DisordersGaucher DiseasePompe DiseaseNiemann-Pick Disease
- First Posted Date
- 2014-04-22
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- O & O Alpan LLC
- Target Recruit Count
- 20000
- Registration Number
- NCT02120235
- Locations
- ๐บ๐ธ
O&O Alpan, LLC, Fairfax, Virginia, United States
Molecular and Cellular Mechanisms of Lysosomal Storage Diseases
- Conditions
- Lysosomal Storage Disorders
- First Posted Date
- 2013-12-04
- Last Posted Date
- 2021-02-23
- Lead Sponsor
- O & O Alpan LLC
- Target Recruit Count
- 80
- Registration Number
- NCT02000310
- Locations
- ๐บ๐ธ
Lysosomal and Rare Disorders Research and Treatment Center, Inc (LDRTC), Fairfax, Virginia, United States
Investigation of Immune Disorders and Deficiencies
- Conditions
- HypogammaglobulinemiaAutoimmune DiseasesInflammatory DiseasesPrimary Immune DeficienciesCommon Variable Immune Deficiencies
- First Posted Date
- 2013-11-13
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- O & O Alpan LLC
- Target Recruit Count
- 343
- Registration Number
- NCT01981785
- Locations
- ๐บ๐ธ
O&O Alpan LLC, Fairfax, Virginia, United States
Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta
Completed
- Conditions
- Fabry Disease
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- O & O Alpan LLC
- Target Recruit Count
- 30
- Registration Number
- NCT01745185
- Locations
- ๐บ๐ธ
O&O Alpan, Fairfax, Virginia, United States
Pregnancy and Birth Outcome in Women With Pompe Disease
Completed
- Conditions
- Pompe Disease
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2016-09-28
- Lead Sponsor
- O & O Alpan LLC
- Target Recruit Count
- 20
- Registration Number
- NCT01556516
- Locations
- ๐บ๐ธ
O&O Alpan, Fairfax, Virginia, United States
Exploration of Immunity in Gaucher Disease
Completed
- Conditions
- Gaucher Disease
- First Posted Date
- 2011-05-23
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- O & O Alpan LLC
- Target Recruit Count
- 33
- Registration Number
- NCT01358188
- Locations
- ๐บ๐ธ
Lysosomal Diseases Research and Treatment Center, CFCT, Fairfax, Virginia, United States
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Phase 1
Completed
- Conditions
- Eosinophilic Esophagitis
- First Posted Date
- 2009-12-29
- Last Posted Date
- 2012-03-14
- Lead Sponsor
- O & O Alpan LLC
- Target Recruit Count
- 19
- Registration Number
- NCT01040598
- Locations
- ๐บ๐ธ
O & O Alpan LLC, Springfield, Virginia, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath